Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 0.0× sales vs its 13.8× historical median P/S.
Fair value ≈ $0.57 · price $0.00 today
Undervalued · 100% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$CYIO added more huge deal about to take place with this JV! Amazing share structure definitely an underdog at these levels!
More official PR will be released shortly, however I can confirm that the definitive agreement has now been signed with our new JV partner.
This positions CYIO to enter a significant market opportunity within the fast-growing health and wellness sector.
Importantly, the structure gives CYIO control across the full process — from manufacturing through to distribution — with revenues and funds managed through the CYIO-controlled U.S. distribution platform.
This is not a concept or startup product. The products are already established and selling in international markets, with the focus now on scaling into the U.S. market.
$AMFN added, I’ll continue to as I can under .15
$NLST added for long term!
@AzureLain
$CYIO official PR will be released shortly, however I can confirm that the definitive agreement has now been signed with our new JV partner.
This positions CYIO to enter a significant market opportunity within the fast-growing health and wellness sector.
Importantly, the structure gives CYIO control across the full process — from manufacturing through to distribution — with revenues and funds managed through the CYIO-controlled U.S. distribution platform.
This is not a concept or startup product. The products are already established and selling in international markets, with the focus now on scaling into the U.S. market.
$TXTM terrible take. 1 year off ce and they have done everything while in tandem to get the stock ready for uplist
you call something a scam cause its not happening at your schedule
while ignoring all the good thats happening and while not ackowledging dr j and dylon have not benefitted at all since they became owners
Combine all they good they have done and you gonna say they dont deserve trust in when they say ”aint if” both profit and income will come?
might as well sell and go buy something like $CYIO they got revenues altho heard they was diluting 🤷♂️
$AMFN just purely a monster I still haven’t opened my account yet where shares sit from RNWF 😂
$AEFI tailing behind it trying to start making its way up.
$EVLI great news time to start moving up
$CYIO of my big 4 this is the only one actually producing revenue, sort of crazy it’s sitting where it is. Just got penny stock exemption and book value is .024+ another huge upside opportunity.
@Stock_profit @realist_1 posted today
$CYIO have been informed that year-end financials are now completed and currently undergoing final legal review prior to release.
This represents a key step forward as the company continues to progress across multiple fronts:
• Financial reporting now aligned and ready for publication
• Legal sign-off underway to ensure full compliance
• Positioning for removal of the Yield Sign
• Continued progress toward OTCQBuplisting pathway
• Audit progression with Year 2 of the Public Company Accounting Oversight Board process commencing
$CYIO part 2 WHEN PEOPLE REALIZE any volume this flies easy, and how undervalued it is. Then many not paying attention will wish they did!
- 401m o/s
- $15,000,000 revenue
- huge joint venture pending
- acquisition pending
- new website in progress
$AABB $NLST $AMFN
U.S. Expansion (Major Catalyst)
Entry into a large and rapidly growing U.S. market via an established platform
→ Existing supply chain
→ Proven demand
→ Early retail momentum
This is execution — not speculation.
• Strategic Funding Alignment
Funding partners engaged to support rollout and accelerate scale
• OTC Status Improvement
Removal of the Yield Sign expected as filings are brought current — a key signal of compliance and progress
• New Website Launch
Updated corporate website in final stages — improving transparency, communication, and investor access
$CYIO has 401m o/s market cap of $820,000 producing $15,000,000 in revenue! How this is sitting at .0021 is insane. Just off revenues it should be .06+ now add all the catalysts plus an acquisition coming! This could easily be a .25+ stock soon. Once people realize and volume comes
$CYIO Over the coming weeks, multiple key milestones are aligning to support a clear and scalable growth narrative:
• 2025 Financials
Year-end financials scheduled for release by April 15
Reflecting strong performance under current global market conditions
• Audit Progress
Year 1 of the two-year Public Company Accounting Oversight Board audit completed
Year 2 now commencing — a major step toward higher market tiering
• Uplisting Pathway
Defined plan targeting OTCQB uplisting by July 2026
Driving improved liquidity and broader investor access
